CUSIP: 64052L106
Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,398,895
-
Share change
-
-697,946
-
Total reported value
-
$64,983,714
-
Put/Call ratio
-
547%
-
Price per share
-
$4.85
-
Number of holders
-
67
-
Value change
-
-$3,972,861
-
Number of buys
-
29
-
Number of sells
-
29
Quarterly Holders Quick Answers
What is CUSIP 64052L106?
CUSIP 64052L106 identifies NEOS - NEOS THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2018
-
Previous quarter:
Q2 2018
Recent filing periods for CUSIP 64052L106:
Institutional Holders of NEOS THERAPEUTICS INC - COM (NEOS) as of Q3 2018
As of 30 Sep 2018,
NEOS THERAPEUTICS INC - COM (NEOS) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,398,895 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, BlackRock Inc., J. Goldman & Co LP, Vanguard Group Inc, SPHERA FUNDS MANAGEMENT LTD., Ghost Tree Capital, LLC, STATE STREET CORP, Russell Investments Group, Ltd., Lyon Street Capital, LLC, and NEXTHERA CAPITAL LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.